✦ LIBER ✦

Increased temporal blood flow associated with visual hallucinations in Parkinson's disease with dementia

✍ Scribed by Hiroshi Kataoka; Yoshiko Furiya; Masami Morikawa; Satoshi Ueno; Makoto Inoue

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 77 KB
Volume: 23
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.21923

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive correlates of visual hallucina

Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease

✍ Kolbjorn Bronnick; Murat Emre; Sibel Tekin; Siri B. Haugen; Dag Aarsland 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## Background: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease de

Frontal and associative visual areas rel

Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia

✍ Cristina Sanchez-Castaneda; Ramon Rene; Blanca Ramirez-Ruiz; Jaume Campdelacreu; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Visual Hallucinations (VH) are among the core features of Dementia with Lewy Bodies (DLB), but are also very frequent in demented patients with Parkinson's Disease (PDD). The purpose of this study was to investigate the pattern of gray matter and cognitive impairment underlying VH in DL

Effects of rivastigmine in patients with

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub

Visual hallucination in Parkinson's dise

Visual hallucination in Parkinson's disease with FDG PET

✍ Atsuko Nagano-Saito; Yukihiko Washimi; Yutaka Arahata; Katsushige Iwai; Shoji Ka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract To determine the characteristics of cerebral glucose metabolism in Parkinson's disease patients with visual hallucinations, group comparison studies using [^18^F]fluorodeoxyglucose positron emission tomography were performed. Nondemented Parkinson's disease patients in advanced stages w

Neuropsychological deficits in Parkinson

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations

✍ Blanca Ramírez-Ruiz; Carme Junqué; María-José Martí; Francesc Valldeoriola; Edua 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Recent neuropathological and neuroimaging studies suggest the involvement of several temporal regions in Parkinson's disease (PD) patients with visual hallucinations (VH). We examined 24 nondemented PD patients with VH, 21 PD patients without VH, and 21 healthy controls using a battery

Visual hallucinations and altered visual

Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies

✍ Akira Kurita; Maiko Murakami; Satoshi Takagi; Masato Matsushima; Masahiko Suzuki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Visual hallucinations (VHs) are common in dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD), while auditory hallucinations are rare. To neurophysiologically investigate the pathophysiology of VHs in these disorders, we studied event‐related potentials (ERPs) of